Maryland biotech seeks about $50 million in IPO
Maryland biotech seeks about $50 million in IPO
Washington Business Journal - 2:28 PM EDT Tuesdayby Neil AdlerStaff Reporter
Print this Article Email this Article Reprints RSS Feeds Most Viewed Most Emailed
The public market for local biotechnology companies continues to stink.
The latest evidence is Osiris Therapeutics, which filed in May to go public, hoping to raise $80 million. This week, the Maryland stem-cell research company amended its IPO application with the Securities and Exchange Commission, and the new information indicates it expects to raise between $44 million and $52 million.
In the new filing, Osiris says it intends to offer 3.5 million shares of common stock at $11 to $13 a share.
more
Washington Business Journal - 2:28 PM EDT Tuesdayby Neil AdlerStaff Reporter
Print this Article Email this Article Reprints RSS Feeds Most Viewed Most Emailed
The public market for local biotechnology companies continues to stink.
The latest evidence is Osiris Therapeutics, which filed in May to go public, hoping to raise $80 million. This week, the Maryland stem-cell research company amended its IPO application with the Securities and Exchange Commission, and the new information indicates it expects to raise between $44 million and $52 million.
In the new filing, Osiris says it intends to offer 3.5 million shares of common stock at $11 to $13 a share.
more
posted by Bill Austin - Maryland biotech seeks about $50 million in IPO
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home